GLA
JAZZ icon

Great Lakes Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Great Lakes Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15M Sell
33,804
-15,141
-31% -$3.32M 0.06% 170
2026
Q1 		$9.25M Sell
48,945
-6,803
-12% -$1.19M 0.08% 154
2025
Q4 		$9.48M Sell
55,748
-9,214
-14% -$1.41M 0.08% 160
2025
Q3 		$8.56M Buy
64,962
+15,962
+33% +$1.91M 0.07% 176
2025
Q2 		$5.2M Sell
49,000
-6,210
-11% -$675K 0.04% 278
2025
Q1 		$6.85M Buy
55,210
+18,768
+52% +$2.45M 0.06% 232
2024
Q4 		$4.49M Buy
+36,442
New +$4.3M 0.04% 335
2024
Q1 		– Sell
-5,435
Closed -$669K – 834
2023
Q4 		$669K Sell
5,435
-2,539
-32% -$317K 0.01% 573
2023
Q3 		$1.03M Sell
7,974
-4,384
-35% -$584K 0.01% 523
2023
Q2 		$1.53M Sell
12,358
-29,066
-70% -$3.91M 0.02% 478
2023
Q1 		$6.06M Buy
41,424
+39,796
+2,444% +$5.89M 0.06% 326
2022
Q4 		$259K Buy
1,628
+42
+3% +$6.16K 0.01% 582
2022
Q3 		$211K Buy
1,586
+110
+7% +$16.7K ﹤0.01% 599
2022
Q2 		$230K Sell
1,476
-261
-15% -$40.2K ﹤0.01% 617
2022
Q1 		$270K Buy
+1,737
New +$252K ﹤0.01% 618
2014
Q4 		– Sell
-4,865
Closed -$781K – 537
2014
Q3 		$781K Buy
+4,865
New +$748K 0.03% 340

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Great Lakes Advisors's JAZZ Position: Q2 2026 in Review

Great Lakes Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 31% in Q2 2026, selling an estimated $3.32M and leaving 33,804 shares worth $8.15M. The position accounts for 0.06% of the portfolio, ranked #170.

Great Lakes Advisors first reported a position in JAZZ in Q3 2014 and has held it in 16 quarters since. The position peaked at $9.48M in Q4 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Great Lakes Advisors held 33,804 shares of Jazz Pharmaceuticals worth $8.15M as of Q2 2026.
  • Great Lakes Advisors sold 15,141 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.32M.
  • Jazz Pharmaceuticals made up 0.06% of Great Lakes Advisors's portfolio in Q2 2026, its #170 holding.
  • Great Lakes Advisors first reported a position in Jazz Pharmaceuticals in Q3 2014 and has held it in 16 quarters since.
  • Great Lakes Advisors's Jazz Pharmaceuticals position peaked at $9.48M in Q4 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.